FundedIQ
Biotechnology

NJ Bio: Funding, Investors & Team (Sep 2026)

NJ Bio offers biology and chemistry support to biotech and pharmaceutical clients. The business began in 2019 and has its main office situated in Princeton, New Jersey, USA.

njbio.com LinkedIn Princeton, United States 51-100 employees
Biopharma Biotechnology Pharmaceutical B2B Custom synthesis Antibody Protein purification Chemistry cro
Total raised
$5.6M
Rounds
1
Latest
Undisclosed round
Mar 2023

NJ Bio has raised $5.6M across 1 funding round on record, the most recent an undisclosed round of $5.6M announced in Mar 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NJ Bio Company Profile and Key Stats

Total funding raised
$5.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$5.6M in Mar 2023
Employees
51-100
reported band
Headquarters
Princeton, United States

Latest funding round on record: Mar 2023.

NJ Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$5.6M

NJ Bio Founders and Leadership Team

Name
Role
Contact
Naresh Jain
CEO

No contact details are on record for this team yet.

NJ Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

NJ Bio's latest round of $5.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NJ Bio in Biotechnology and Princeton

Companies Similar to NJ Bio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

NJ Bio Funding FAQs

What does NJ Bio do?

NJ Bio offers biology and chemistry support to biotech and pharmaceutical clients. The business began in 2019 and has its main office situated in Princeton, New Jersey, USA.

How much funding has NJ Bio raised?

NJ Bio has raised $5.6M across 1 round on record. The most recent is an undisclosed round of $5.6M announced in Mar 2023.

When did NJ Bio last raise funding?

NJ Bio's most recent funding round on record is an undisclosed round of $5.6M, announced in Mar 2023.

Who is the CEO of NJ Bio?

Naresh Jain is listed as CEO at NJ Bio.

Where is NJ Bio headquartered?

NJ Bio is based in Princeton, New Jersey, United States.

How many employees does NJ Bio have?

NJ Bio is in the 51-100 employee band.

How does NJ Bio's funding compare to other Biotechnology startups?

NJ Bio's latest round of $5.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's NJ Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NJ Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.